BIENOX 100 UNITS

Bienox 100U is designed to temporarily reduce muscle activity responsible for expression lines while preserving natural facial movement when appropriately administered. It is widely used in aesthetic medicine for facial rejuvenation and may also be used for approved therapeutic indications by trained medical professionals.

Indications

Bienox 100U is commonly used for the temporary improvement of:

• Glabellar (frown) lines

• Forehead lines

• Crow's feet

• Bunny lines on the nose

• Chin dimpling

• Perioral (lip) lines

• Jawline contouring through masseter muscle treatment

• Neck bands (platysmal bands), where clinically appropriate

Therapeutic indications vary by country and local regulatory approval.

Composition

Each vial contains:

• Clostridium Botulinum Toxin Type A – 100 Units

• Human Serum Albumin – 0.5 mg

• Sodium Chloride – 0.9 mg

Supplied as a sterile, vacuum-dried (lyophilized) powder for reconstitution prior to injection.

Key Benefits

• Highly purified Botulinum Toxin Type A formulation

• Helps soften moderate to severe dynamic facial wrinkles

• Produces natural-looking facial rejuvenation when administered correctly

• Rapid onset of visible effects, often within several days

• Results generally last around 3–4 months, depending on the individual and treatment area

• Suitable for a variety of aesthetic facial applications

• Manufactured under pharmaceutical quality standards in South Korea

Treatment Areas

Suitable for treatment of:

• Forehead

• Glabella (between the eyebrows)

• Crow's feet

• Nose

• Chin

• Jawline (masseter)

• Neck (platysmal bands)

Administration

Bienox 100U should be reconstituted and administered only by qualified healthcare professionals experienced in botulinum toxin injections. Dosage, dilution, injection sites, and treatment intervals should be determined according to the patient's anatomy, clinical needs, and approved local labeling.

Expected Results

Initial improvement is commonly observed within 3–7 days, with peak effects developing after approximately 10–14 days. Clinical effects generally persist for 3–4 months, although duration varies among individuals.

Packaging

• 1 sterile vial × 100 Units

• Lyophilized powder for solution for injection

Origin

Country of Manufacture: South Korea

Manufacturer: BMI Korea Co., Ltd. / Korea BNC (market-dependent)

Storage

• Store refrigerated at 2°C–8°C.

• Keep the vial sealed and protected from light.

• Do not freeze.

• Use according to the manufacturer's instructions after reconstitution.

Precautions

• For professional use only.

• Administration should only be performed by licensed healthcare professionals trained in botulinum toxin procedures.

• Do not use in patients with known hypersensitivity to any component of the product.

• Temporary injection-site reactions such as redness, swelling, bruising, or tenderness may occur.

• Patients with neuromuscular disorders or active infection at the injection site require careful medical evaluation before treatment.

Product Specifications